Friday, March 15, 2024 9:35:32 AM
I looked at the action. Almost all trades on the offer. So that's a positive. But can't last forever without news.
I assume you saw HEP Investments (Laith Yaldoo) post an updated 13D yesterday for 488K shares. Guess his group still holding a pile of stock. It is amazing to me he files a 13D and still holds. If you don't know, filing 13D is an indication that you intend to influence company mgmt vs 13G that is declaring passive intent.
Yaldoo IMO ... was and is part of the problem rather than the solution. Although now ZIVO has a CEO that has a clue. Yeah he funded ZIVO for several years but the condition of his funding was Dahl being CEO and his money allowed him to attend BoD meetings. He has zero background in bio/agtech science anything. And neither did Dahl. Of course now he's losing his shirt on this investment with ZIVO being YEARS behind where it should be.
There are tons of thing ZIVO could be doing now that they aren't. ZIVOLife for instance, can't wait to see the numbers on that. Not expecting much. But gut health, joint health, inflammation, sports recovery, covid .... the possibilities are massive. LIke I said I would have done side by side on glucosamine. CRP is an easy blood test for inflammation. I'd directly be comparing against AG1 that you see all over the place now. Of course there is that problem of can't produce in massive quantities. Although my due dilly yields pics of Alimenta's grow facility appears to have expanded with new raceway pond(s). There is at least 1 new one from last I saw and maybe more. ZIVO could easily update website on production progress with little to no effort.
But of course the elephant in the room is the coccidiosis license with one of the big boyz. Tic Toc .......... I can understand ZIVO being mum on that, but there are other things that can be shared with investors.
A couple of 1k+ offers at 8.99 to start the day.... =) I am still sitting patient with my swing position from 60 cents and already posted the sell to cover the investment so sitting on house money and waiting. And still of the opinion this thing should be sitting at $20 with the final coccidiosis results proven which doesn't even put the ZIVO market cap back where it sat historically.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM